Stock CPRX CATALYST PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Catalyst Pharmaceuticals, Inc.

Equities

CPRX

US14888U1016

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
15.94 USD +1.85% Intraday chart for Catalyst Pharmaceuticals, Inc. +8.29% -5.18%
May. 10 HC Wainwright Adjusts Catalyst Pharmaceuticals' Price Target to $26 From $24, Keeps Buy Rating MT
May. 09 Transcript : Catalyst Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CATALYST PHARMACEUTICALS, INC. Stock Catalyst Pharmaceuticals, Inc.
 1.88B -
CSL LIMITED Stock CSL Limited
 89.08B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 40.9B
BIOGEN INC. Stock Biogen Inc.
 32.25B
UCB Stock UCB
 25.14B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 15.39B
  1. Stock Market
  2. Equities
  3. CPRX Stock
  4. Charts Catalyst Pharmaceuticals, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW